Skip to main content
ConductScienceScienceDex
Powered by ShareScore

Find research datasets worth reusing

Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.

6,348

datasets available to search

ShareScore release 0.9.0

Reset

Dataset results

6,348 results for “hepatitis”

Learn how ShareScore rates datasets ↗
dryad32/100

Medium-chain fatty acids suppress lipotoxicity-induced hepatic fibrosis via the immunomodulating receptor GPR84

<p><span>Medium-chain triglycerides (MCTs), which consist of medium-chain fatty acids (MCFAs), are unique forms of dietary fat with various health benefits. GPR84 acts as a receptor for MCFAs (especially C10:0 and C12:0); however, GPR84 is still considered an orphan receptor, and </span><span>the</span><span> nutritional signaling of endogenous and dietary MCFAs via GPR84 remains unclear. Here, we showed that endogenous MCFA-mediated GPR84-signaling protected hepatic functions from diet-induced lipotoxicity. Under high-fat diet (HFD) conditions, GPR84-deficient mice exhibited </span><span>non-alcoholic steatohepatitis (NASH) and the progression of hepatic fibrosis but not steatosis.</span> <span>With markedly increased hepatic MCFA levels under HFD, GPR84 suppressed lipotoxicity-induced macrophage over-activation. Thus, GPR84 is an immunomodulating receptor that suppresses excessive dietary fat intake-induced toxicity by sensing increases in MCFAs. Additionally, administering MCTs, MCFAs (C10:0 or C12:0, but not C8:0), or GPR84 agonists effectively prevented NASH in mouse models. Exogenous GPR84 stimulation is therefore a breakthrough strategy for treating NASH</span><span>.</span></p>

opencc-zeroJun 2022View details →
zenodo32/100

Complementary hepatic metabolomics and proteomics reveal the adaptive mechanisms of dairy cows to the transition period

<p>Gas chromatography quadrupole-time-of-flight mass spectrometry-based metabolomics and data-independent acquisition-based quantitative proteomics methods were used to analyze liver tissues collected from eight healthy multiparous Holstein dairy cows on 21 days before and after calving.</p>

opencc-by-4.0Dec 2022View details →
zenodo32/100

A Multi-Scale Spatial Model of Hepatitis-B Viral Dynamics

<p>Dataset related to an accepted manuscript:</p> <p>A Multi-Scale Spatial Model of Hepatitis-B Viral Dynamic. Cangelosi  Q., Means S., Ho H. PLOS One</p> <p>Dataset documented in a ReadMe file.</p>

opencc-by-4.0Nov 2017View details →
dryad32/100

Hepatitis B vaccination coverage and associated factors among personnel working in health facilities in Kumasi, Ghana

<p>As part of efforts to reach the elimination target by 2030, the WHO and CDC recommend that all healthcare workers (HCWs) adhere to the 3-dose hepatitis B vaccination schedule to protect themselves against the infection. This study assessed Hepatitis B vaccination coverage and associated factors among personnel working in health facilities in Kumasi, Ghana. A cross-sectional study involving 530 HCWs was conducted in four hospitals in Kumasi from September to November 2023. An investigator-administered questionnaire was employed in gathering participant demographics and other information related to vaccination coverage. IBM SPSS version 26.0 and GraphPad Prism 8.0 were used for analysing the data. Even though, the majority (70.6%) reported having taken at least one dose of the vaccine, only 43.6% were fully vaccinated (≥ 3 doses). More than a quarter (29.4%) had not taken any dose of the HBV vaccine. Close to a quarter (23.6%) had not screened or tested for HBV infection in their lifetime. The Statistically significant variables influencing vaccination status were age, marital status, profession, and status in the hospital. The majority (44.9%) of the participants who have not taken the vaccine reported they do not have a reason for not taking the vaccine and a high proportion (80.1%) were willing to take the vaccine when given for free. To combat the low hepatitis B vaccination coverage among healthcare workers in Kumasi, Ghana, amidst the significant public health threat of HBV infection, comprehensive measures are necessary. These include implementing infection prevention control programmes, enhancing occupational health and safety, and conducting health promotion campaigns in healthcare facilities. Extending and intensifying hepatitis B screening and vaccination initiatives to tertiary institutions and encouraging employers, supervisors, or team leaders to provide these services nationwide are also recommended.</p>

opencc-zeroApr 2024View details →
zenodo32/100

Prevalence of hepatitis A virus among migrant workers in Qatar

<p>Database of a cross-sectional survey to estimate the prevalence of hepatitis A virus among migrant workers in Qatar.</p>

opencc-by-4.0Jun 2024View details →
zenodo32/100

Radix Sophorae flavescentis for chronic hepatitis B - Characteristics of potential randomised clinical trials

<p>This table listed the references considered to be potential randomised clinical trials on Radix Sophorae flavescentis for chronic hepatitis B, as we could not attain any response from the authors about their randomisation method. We also listed the results of contacting authors.&nbsp;</p> <p>&nbsp;</p>

opencc-by-4.0Oct 2018View details →
zenodo32/100

Comparative Analysis of Gut Microbiota in Hepatocellular Carcinoma and Hepatitis

<p><span><span>&nbsp;</span></span><span>The differential abundance of flora was modeled using support vector machine (SVM) methodology. Predictive performance for hepatocellular carcinoma and hepatitis was assessed using the model. 3 genera including <em>Paraprevotella</em>, <em>Pasteurellaceae</em>, and <em>Prevotellaceae</em> showed superior predictive performance for HCC, whereas <em>Oscillibacter</em>, <em>Clostridium_XVIII</em>, while 5 genera including <em><span>&nbsp;</span>Eggerthella</em> exhibited better predictive ability for HBV.</span></p> <p><span>&nbsp;</span></p>

opencc-by-4.0Sep 2024View details →
dryad32/100

Data from: Peripheral TNFa elevations in abstinent alcoholics are associated with Hepatitis C infection

Substantial evidence supports the view that inflammatory processes contribute to brain alterations in HIV infection. Mechanisms recently proposed to underlie neuropathology in Alcohol Use Disorder (AUD) include elevations in peripheral cytokines that sensitize the brain to the damaging effects of alcohol. This study included 4 groups: healthy controls, individuals with AUD (abstinent from alcohol at examination), those infected with HIV, and those comorbid for HIV and AUD. The aim was to determine whether inflammatory cytokines are elevated in AUD as they are in HIV infection. Cytokines showing group differences included interferon gammainduced protein 10 (IP-10) and tumor necrosis factor α (TNFα). Follow-up t-tests revealed that TNFα and IP-10 were higher in AUD than controls but only in AUD patients who were seropositive for Hepatitis C virus (HCV). Specificity of TNFα and IP10 elevations to HCV infection status was provided by correlations between cytokine levels and HCV viral load and indices of liver integrity including albumin/globulin ratio, fibrosis scores, and AST/platelet count ratio. Because TNFα levels were mediated by HCV infection, this study provides no evidence for elevations in peripheral cytokines in "uncomplicated", abstinent alcoholics, independent of liver disease or HCV infection. Nonetheless, these results corroborate evidence for elevations in IP-10 and TNFα in HIV and for IP-10 levels in HIV+HCV coinfection.

opencc-zeroDec 2017View details →
dryad32/100

Spatial reconstruction of the early hepatic transcriptomic landscape after an acetaminophen overdose using single-cell RNA sequencing

<p>We leveraged single-cell RNA sequencing to understand the early molecular events that define the hepatocyte response to acetaminophen exposure at a subpopulation level. We spatially assigned hepatocytes along the portol-central vein axis by using established landmark genes. By spatially assigning the hepatocytes were were able to account for innate differences in gene expression that existed along this gradient. The excel files herein provide the full list of differentially expressed genes between key subpopulations of interest. Additionally, we classified genes as either pericentral zonated, periportal zonated, or non-zonated, the full list of genes and their spatial assignments are included in the appropriate excel file. </p>

opencc-zeroAug 2021View details →
dryad32/100

New incidence or recurrence hepatocellular carcinoma (HCC) in genotype 4 hepatitis C virus treated with sofosbuvir/daclatasvir with or without ribavirin

<p><span><b>Background</b>: Several studies have resulted in controversial data about the recurrence or new incidence of hepatocellular carcinoma (HCC) in patients with hepatitis C who were treated with direct-acting antivirals (DAAs).  </span></p> <p><span><b>Aim:</b> This observational study aimed to assess the occurrence rate of HCC in patients who developed a sustained virological response (SVR).. </span></p> <p><span><b>Methods</b>: A six-month prospective study was done at the National Hepatology and Tropical Medicine Research Institute [NHTMRI] in Cairo, Egypt on 150 chronic hepatitis C (CHC) patients treated with sofosbuvir and daclatasvir with or without ribavirin. Patients were assigned into two groups according to their laboratory values to either receive sofosbuvir/daclatasvir and ribavirin (S/D/R) or receive only sofosbuvir/daclatasvir (S/D). The main outcome measure was the occurrence of HCC.</span></p> <p><span><b>Results</b>: SVR-12 was 100%. 8.5% of patients developed HCC in the S/D/R group, while 0% in the S/D group.</span></p> <p><span><b>Conclusion:</b>  New incidence or recurrence of HCC may occur in CHC genotype 4 cirrhotic patients receiving sofosbuvir/daclatasvir and ribavirin (difficult to treat) although achieving SVR. The cause of HCC development in this study is cirrhosis, not the administered DAAs.</span></p>

opencc-zeroFeb 2022View details →
zenodo32/100

Dataset of "Mutation in Smek2 regulating hepatic glucose metabolism causes hypersarcosinemia and hyperhomocysteinemia in rats"

<p>We fed ExHC rats and Congenic (ExHC.BN-<em>Dihc2<sup>BN</sup></em>) rats on two diets (0%- or 2%-cholesterol semi-purified AIN76-based diet) for 2 weeks. We measured the parameters related to homocysteine and lipid metabolism in the obtained samples. This data set includes raw data of hepatic microarray analysis with ExHC and Congenic rats. Additionally, we measured Smek2 and Sardh mRNA in rat hepatic cell line (MCA-RH7777) under Smek2 knock-down condition.</p>

opencc-by-4.0Nov 2022View details →
zenodo32/100

Simulated hepatitis B virus (HBV) sequencing data and HBV sequence variation graph materials

<p>Simulated HBV sequencing data (InSilicoSeq, HiSeq error model) and a sequence variation graph constructed using HBV genome sequences described in <a href="https://doi.org/10.1099/jgv.0.001387">https://doi.org/10.1099/jgv.0.001387</a></p>

opencc-by-4.0Jun 2022View details →
zenodo32/100

Data set of HRQoL of hepatitis C patients visiting public hospitals of Lahore, Pakistan

<p>The attached file&nbsp;contains the data set for&nbsp;Health related quality of life among hepatitis C patients: A cross-sectional study conducted in public hospitals of Lahore, Pakistan study.</p>

opencc-by-4.0Jan 2023View details →
zenodo32/100

Gut microbiota as mediator and moderator between hepatitis B virus and hepatocellular carcinoma

<p>A STORMS (Strengthening The Organizing and Reporting of Microbiome Studies) checklist is available here.</p>

opencc-by-4.0Aug 2023View details →
ClinicalTrials.gov32/100

A Clinical Evaluation on Traditional Chinese Medicine Diagnosis and Treatment Program Blocking and Reversing Hepatitis B-related Liver Fibrosis - a Randomized, Controlled, Double-blind, Multi-center C

ClinicalTrials.gov study NCT01965418. IPD Sharing: Not stated. Countries: 1. Publications: 2.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

Pigtail Catheter: a Less Invasive Option for Pleural Drainage of Recurrent Hepatic Hydrothorax

ClinicalTrials.gov study NCT02119169. IPD Sharing: Not stated. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

Clinical Trial of FCN-437c Capsule in Patients With Hepatic Insufficiency

ClinicalTrials.gov study NCT06620731. IPD Sharing: NO. Countries: 1. Publications: 1.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

Intra-dermal With Topical Imiquimod Pretreatment Versus Intra-muscular Hepatitis B Vaccination in IBD Patients

ClinicalTrials.gov study NCT04083157. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

Safety and Efficacy of Albumin Interferon Administered Every 4 Weeks in Genotype 2/3 Hepatitis C Patients

ClinicalTrials.gov study NCT00759200. IPD Sharing: Not stated. Countries: 12. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

Study of Automatic Image Fusion of a CT Volume With Ultrasound During Percutaneous Ablation Treatment of Hepatic Tumors

ClinicalTrials.gov study NCT04420026. IPD Sharing: Not stated. Countries: 1. Publications: 5.

restrictedIPD-UNDECIDEDFeb 2026View details →

ScienceDex guides

Understand access before you commit

These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.

Compare curated datasets

Allen Brain Atlas

Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.

allen-brain-atlas
neuroscienceopenDocumentation, web resources, and API references are available online.
Last verified 2026-04-30Open record

Annotated Behaviour and Observability Dataset (ABODe)

ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.

abode-home-cage
behavioral-neuroscienceopenThe DataShare record exposes download links for annotations, documentation, license text, and the zipped per-snippet data directory.
Last verified 2026-04-30Open record

DANDI Archive for NWB datasets

DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.

dandi-nwb
electrophysiologyopenPublished Dandiset metadata and archive endpoints are available through the production DANDI API.
Last verified 2026-04-30Open record

International Brain Laboratory public data

The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.

ibl
behavioral-neuroscienceopenPublic sessions can be searched and loaded from the IBL public data server through ONE.
Last verified 2026-04-29Open record

OpenNeuro

OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.

openneuro
neuroscienceopenPublished datasets are available on demand over the internet.
Last verified 2026-04-29Open record

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.